James F. Oliviero III, Chief Financial Officer at KERYX BIOPHARMACEUTICALS INC (KERX), sold 1,475 shares at $10.25 ($15K) on 2013-10-03, disclosed to the SEC on 2013-10-07.
Seasonal sale ($15k) by Chief Financial Officer — this insider has traded KERX in October in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| CKPT | SELL | 2024-12-20 | $6.1M | — | Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |